Hypertension, Vol 17, 944-950, Copyright © 1991 by American Heart Association
S Bova, MP Blaustein, JH Ludens, DW Harris, DW DuCharme and JM Hamlyn
An endogenous ouabainlike compound (OLC) has been purified from human
plasma, and mass spectrometry has shown it to be indistinguishable from
plant-derived ouabain. This human OLC was tested for its effects on evoked
tension in guinea pig left atria and aortic rings. The tissues were
incubated at 37 degrees C in bicarbonate-buffered physiological salt
solution gassed with 95% O2-5% CO2. In atria stimulated electrically at 1
Hz, 85 and 170 nM human OLC increased peak active force to 177 +/- 15% and
313 +/- 32% of control, respectively (n = 3), with little effect on the
duration of contraction. On washout of the OLC, peak systolic force
returned to the control level with a half-time of 4.3 +/- 0.5 minutes.
Similar results were obtained with 160 nM plant- derived ouabain: peak
systolic force increased to 310 +/- 31% of control (n = 4) and returned to
the control level with a half-time of 3.8 +/- 0.2 minutes during washout.
In aortic rings, neither 170 nM human OLC nor 160 nM plant ouabain
(30-minute treatments) affected resting (unstimulated) tension, but they
increased the contractions evoked by histamine (0.2-1.0 microM) to 156 +/-
13% (n = 4) and 143 +/- 6% (n = 4) of control responses, respectively. The
mean half-time for washout of the OLC and plant ouabain-induced
augmentation of histamine- evoked tension exceeded 35 minutes. These data
show that human OLC has cardiotonic and vasotonic actions qualitatively and
quantitatively similar to those observed with plant ouabain.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Effects of an endogenous ouabainlike compound on heart and aorta
Department of Pharmacology, University of Padua, Italy.
This article has been cited by other articles:
![]() |
W. Schoner and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Blaustein, J. Zhang, L. Chen, and B. P. Hamilton How does salt retention raise blood pressure? Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R514 - R523. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Manunta, B. P. Hamilton, and J. M. Hamlyn Salt intake and depletion increase circulating levels of endogenous ouabain in normal men Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R553 - R559. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Balzan, D. Neglia, S. Ghione, G. D'Urso, M. C. Baldacchino, U. Montali, and A. L'Abbate Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction Eur J Heart Fail, March 1, 2001; 3(2): 165 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Manunta, P. Stella, R. Rivera, D. Ciurlino, D. Cusi, M. Ferrandi, J. M. Hamlyn, and G. Bianchi Left Ventricular Mass, Stroke Volume, and Ouabain-Like Factor in Essential Hypertension Hypertension, September 1, 1999; 34(3): 450 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ferrandi, P. Manunta, S. Balzan, J. M. Hamlyn, G. Bianchi, and P. Ferrari Ouabain-like Factor Quantification in Mammalian Tissues and Plasma : Comparison of Two Independent Assays Hypertension, October 1, 1997; 30(4): 886 - 896. [Abstract] [Full Text] |
||||
![]() |
A. Goto, K. Yamada, H. Hazama, Y. Uehara, K. Atarashi, Y. Hirata, K. Kimura, and M. Omata Ouabainlike Compound in Hypertension Associated With Ectopic Corticotropin Syndrome Hypertension, September 1, 1996; 28(3): 421 - 425. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |